AN INTERESTING CASE OF PROSTHETIC VALVE THROMBOSIS POSING THERAPEUTIC CHALLENGE IN PREGNANCY
Abstract
Pregnant females presenting with prosthetic valve thrombosis carries high morbidity and mortality if not timely intervened. In the few reported cases of prosthetic mitral valve thrombosis, where surgical intervention was considered as high risk, fibrinolytic therapy was utilized and found to be life saving. We present clinical, laboratory, and imaging data from a pregnant patient, with prosthetic mitral valve thrombosis and its successful management with tenecteplase. The use of tenecteplase as a viable fibrinolytic agent was justified, due to the immunogenicity concerns of streptokinase.
Full Text:
PDFReferences
Grunkemeier GL, Li HH, Naftel DC, Starr A, Rahimtoola SH. Long-term performance of heart valve prostheses. Curr Probl Cardiol 2000;25:73-154.
Sharma KH, Mewada NM. Efficacy and safety of streptokinase in prosthetic valve thrombosis (total 5 years clinical registry). Indian J Pharmacol 2010;42:330–331.
Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med. 2000;160:191–196.
Weiss BM, von Segesser LK, Alon E, Seifert B, Turina MI. Outcome of cardiovascular surgery and pregnancy: a systematic review of the period 1984-1996. Am J Obstet Gynecol. 1998;179(pt 1):1643–1653
Caceres-Loriga FM, Perez-Lopez H, Santos-Gracia J, Morlans- Hernandez K. Prosthetic heart valve thrombosis: Pathogenesis, diagnosis and management. Int J Cardiol 2005;110(1):1–6
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
An initiative of The Tamil Nadu Dr M.G.R. Medical University